0009

CN:COM:999

华润三九医药股份有限公司

  • Stock

Last Close

47.47

22/11 07:04

Market Cap

52.85B

Beta: -

Volume Today

9.65M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
911.82M
-
929.13M
1.90%
884.43M
4.81%
907.68M
2.63%
1.00B
10.72%
1.32B
31.28%
1.48B
12.40%
1.60B
7.69%
2.04B
27.43%
2.40B
18.11%
3.81B
58.33%
average payables
877.50M
-
879.68M
0.25%
825.10M
6.21%
914.09M
10.79%
1.02B
11.36%
1.09B
6.77%
1.03B
4.82%
1.07B
3.68%
1.27B
18.11%
1.61B
26.74%
2.08B
29.57%
average receivables
2.07B
-
2.10B
1.60%
2.24B
6.45%
2.66B
18.98%
3.43B
28.97%
4.26B
24.09%
5.14B
20.64%
5.41B
5.27%
5.36B
0.94%
5.87B
9.49%
7.33B
24.91%
book value per share
6.27
-
6.92
10.39%
7.76
12.16%
8.77
13.10%
10.05
14.57%
11.04
9.81%
12.81
16.05%
14.01
9.34%
15.62
11.49%
17.23
10.31%
19.38
12.48%
capex per share
-0.36
-
-0.35
3.46%
-0.34
2.97%
-0.36
6.52%
-0.38
6.10%
-0.61
59.85%
-0.55
10.72%
-0.63
16.10%
-0.89
40.24%
-0.96
8.30%
-0.88
9.13%
capex to depreciation
-1.53
-
-1.45
5.09%
-1.41
2.64%
-1.25
11.36%
-1.17
6.73%
-1.72
46.90%
-1.60
6.85%
-1.59
0.76%
-1.83
15.13%
-1.82
0.45%
-1.00
44.84%
capex to operating cash flow
-0.24
-
-0.29
19.12%
-0.26
8.90%
-0.25
3.02%
-0.24
5.64%
-0.31
30.80%
-0.27
13.47%
-0.28
2.86%
-0.47
66.50%
-0.32
32.01%
-0.20
35.83%
capex to revenue
-0.05
-
-0.05
3.09%
-0.04
10.75%
-0.04
5.74%
-0.03
14.58%
-0.04
32.67%
-0.04
18.46%
-0.05
25.08%
-0.06
24.66%
-0.05
7.40%
-0.04
33.43%
cash per share
1.39
-
1.10
20.48%
0.93
16.18%
0.86
7.29%
1.67
94.26%
2.44
46.33%
3.00
22.90%
4.10
36.97%
4.38
6.66%
3.19
27.13%
8.40
163.47%
days of inventory on hand
118.12
-
111.40
5.69%
108.36
2.73%
98.22
9.36%
103.23
5.10%
134.53
30.33%
108.25
19.54%
125.59
16.02%
136.55
8.72%
109.72
19.65%
157.34
43.41%
days payables outstanding
122.11
-
94.18
22.87%
110.03
16.82%
98.10
10.84%
105.75
7.80%
91.37
13.59%
77.63
15.04%
79.68
2.64%
83.74
5.10%
78.82
5.88%
72.79
7.64%
days sales outstanding
102.50
-
100.85
1.61%
113.74
12.78%
116.20
2.16%
131.41
13.10%
122.66
6.66%
143.03
16.61%
135.27
5.42%
134.84
0.32%
122.57
9.10%
128.03
4.45%
debt to assets
0.05
-
0.05
2.66%
0.04
18.58%
0.04
7.84%
0.03
14.66%
0.00
92.31%
0.00
20.54%
0.01
200.48%
0.01
41.95%
0.01
69.02%
0.10
560.28%
debt to equity
0.09
-
0.08
7.79%
0.07
18.09%
0.06
8.67%
0.05
10.70%
0.00
92.22%
0.00
23.64%
0.01
201.10%
0.01
40.82%
0.02
69.45%
0.20
776.50%
dividend yield
0.01
-
0.01
15.64%
0.02
21.21%
0.01
55.89%
0.01
1.33%
0.02
196.10%
0.01
39.47%
0.02
40.19%
0.01
15.47%
0.02
26.16%
0.02
9.66%
earnings yield
0.05
-
0.05
3.27%
0.05
0.23%
0.05
5.22%
0.05
0.37%
0.06
20.45%
0.07
14.00%
0.07
3.87%
0.06
6.53%
0.05
13.27%
0.06
10.62%
enterprise value
23.60B
-
21.55B
8.68%
26.17B
21.44%
23.89B
8.72%
25.11B
5.11%
21.57B
14.10%
28.06B
30.06%
20.65B
26.39%
30.65B
48.42%
43.46B
41.80%
46.27B
6.46%
enterprise value over ebitda
13.80
-
13.79
0.08%
14.37
4.21%
13.06
9.15%
13.22
1.23%
10.11
23.53%
8.88
12.18%
7.61
14.25%
9.62
26.34%
11.90
23.77%
10.57
11.21%
ev to operating cash flow
16.08
-
18.19
13.14%
20.77
14.17%
17.16
17.39%
16.09
6.23%
11.29
29.87%
14.23
26.06%
9.29
34.74%
16.39
76.47%
14.46
11.77%
10.96
24.17%
ev to sales
3.02
-
2.96
2.09%
3.31
11.86%
2.66
19.71%
2.26
15.10%
1.61
28.86%
1.91
18.79%
1.51
20.64%
2.00
32.12%
2.40
20.16%
1.89
21.32%
free cash flow per share
1.13
-
0.86
23.90%
0.95
10.34%
1.06
11.02%
1.21
14.61%
1.34
10.32%
1.46
9.55%
1.63
11.66%
1.02
37.51%
2.08
103.71%
3.44
65.10%
free cash flow yield
0.05
-
0.04
16.41%
0.03
8.41%
0.04
22.56%
0.05
5.52%
0.05
21.04%
0.05
15.35%
0.07
41.84%
0.03
54.48%
0.04
49.01%
0.07
55.40%
graham net net
-0.38
-
-0.67
75.01%
-1.17
74.10%
-1.42
21.27%
-0.90
36.21%
-0.33
64.03%
0.77
336.55%
0.76
1.48%
1.11
46.63%
-0.64
158.04%
1.84
384.78%
graham number
13.03
-
12.84
1.41%
14.95
16.38%
15.52
3.83%
17.34
11.76%
19.04
9.79%
24.92
30.84%
22.66
9.04%
27.11
19.61%
31.00
14.37%
35.65
14.97%
income quality
1.21
-
1.10
8.56%
0.99
10.54%
1.15
16.63%
1.18
2.05%
1.30
10.16%
0.92
28.87%
1.37
49.16%
0.90
34.62%
1.20
33.94%
1.48
22.87%
intangibles to total assets
0.21
-
0.22
4.22%
0.29
33.76%
0.37
26.39%
0.34
7.32%
0.31
9.07%
0.27
12.43%
0.30
12.12%
0.28
9.24%
0.25
9.87%
0.13
48.68%
interest coverage
62.59
-
44.48
28.94%
51.74
16.34%
45.94
11.21%
53.99
17.51%
65.93
22.12%
573.96
770.52%
406.85
29.12%
185.23
54.47%
138.84
25.04%
39.04
71.88%
interest debt per share
0.57
-
0.59
2.64%
0.54
7.69%
0.56
3.14%
0.57
2.18%
0.07
87.27%
0.05
37.34%
0.14
208.12%
0.23
60.86%
0.42
85.21%
4.00
857.21%
inventory turnover
3.09
-
3.28
6.03%
3.37
2.80%
3.72
10.32%
3.54
4.85%
2.71
23.27%
3.37
24.28%
2.91
13.81%
2.67
8.02%
3.33
24.45%
2.32
30.27%
invested capital
0.09
-
0.08
7.79%
0.07
18.09%
0.06
8.67%
0.05
10.70%
0.00
92.22%
0.00
23.64%
0.01
201.10%
0.01
40.82%
0.02
69.45%
0.20
776.50%
market cap
24.42B
-
22.14B
9.33%
26.64B
20.32%
24.28B
8.87%
26.29B
8.27%
24.01B
8.66%
31.07B
29.40%
24.44B
21.33%
33.51B
37.09%
46.22B
37.94%
48.68B
5.32%
net current asset value
1.29B
-
1.45B
12.17%
868.20M
40.19%
252.07M
70.97%
772.86M
206.61%
1.72B
121.91%
3.07B
79.07%
2.97B
3.16%
3.88B
30.56%
2.40B
38.22%
7.10B
195.97%
net debt to ebitda
-0.48
-
-0.38
21.04%
-0.26
31.77%
-0.21
17.72%
-0.62
190.30%
-1.14
84.45%
-0.95
16.58%
-1.40
46.45%
-0.90
35.84%
-0.76
15.74%
-0.55
27.10%
net income per share
1.20
-
1.06
11.94%
1.28
20.75%
1.22
4.69%
1.33
9.02%
1.46
9.77%
2.15
47.53%
1.63
24.32%
2.09
28.32%
2.48
18.57%
2.91
17.52%
operating cash flow per share
1.50
-
1.21
18.96%
1.29
6.51%
1.42
9.84%
1.59
12.44%
1.95
22.21%
2.01
3.18%
2.27
12.87%
1.91
15.77%
3.04
59.29%
4.31
41.60%
payables turnover
2.99
-
3.88
29.65%
3.32
14.40%
3.72
12.16%
3.45
7.24%
3.99
15.73%
4.70
17.70%
4.58
2.57%
4.36
4.86%
4.63
6.25%
5.01
8.27%
receivables turnover
3.56
-
3.62
1.63%
3.21
11.33%
3.14
2.11%
2.78
11.58%
2.98
7.14%
2.55
14.25%
2.70
5.74%
2.71
0.32%
2.98
10.01%
2.85
4.26%
research and ddevelopement to revenue
0.03
-
0.03
25.28%
0.03
6.04%
0.03
6.68%
0.03
16.26%
0.03
0.89%
0.03
13.41%
0.03
12.19%
0.04
8.44%
0.03
10.16%
0.03
20.18%
return on tangible assets
0.15
-
0.12
14.84%
0.15
18.10%
0.14
4.64%
0.12
12.78%
0.12
5.60%
0.14
25.31%
0.10
27.67%
0.12
11.52%
0.12
3.33%
0.08
32.22%
revenue per share
7.95
-
7.45
6.35%
8.09
8.71%
9.15
13.01%
11.36
24.20%
13.69
20.49%
14.99
9.50%
13.91
7.17%
15.65
12.50%
18.31
16.96%
24.99
36.49%
roe
0.19
-
0.15
20.22%
0.16
7.67%
0.14
15.73%
0.13
4.84%
0.13
0.03%
0.17
27.13%
0.12
30.79%
0.13
15.09%
0.14
7.49%
0.15
4.48%
roic
0.18
-
0.14
20.05%
0.15
4.13%
0.12
21.00%
0.13
8.13%
0.13
5.62%
0.17
24.32%
0.12
29.80%
0.14
15.18%
0.14
4.97%
0.13
8.36%
sales general and administrative to revenue
0.02
-
0.02
24.31%
0.02
6.76%
0.02
5.06%
0.02
12.93%
0.01
13.67%
0.02
23.13%
0.02
7.69%
0.02
4.65%
0.01
15.20%
shareholders equity per share
6.27
-
6.92
10.39%
7.76
12.16%
8.77
13.10%
10.05
14.57%
11.04
9.81%
12.81
16.05%
14.01
9.34%
15.62
11.49%
17.23
10.31%
19.38
12.48%
stock based compensation to revenue
-0.07
-
tangible asset value
4.23B
-
4.68B
10.70%
4.18B
10.63%
3.74B
10.48%
4.61B
23.19%
5.59B
21.17%
7.43B
33.03%
7.37B
0.85%
9.01B
22.24%
10.79B
19.80%
19.60B
81.70%
tangible book value per share
4.31
-
4.79
11.15%
4.28
10.51%
3.81
11.01%
4.71
23.58%
5.69
20.90%
7.58
33.05%
7.52
0.78%
9.20
22.41%
10.93
18.73%
20.03
83.28%
working capital
2.16B
-
2.45B
13.55%
1.91B
22.03%
1.30B
32.24%
1.34B
3.38%
2.26B
68.76%
3.60B
59.28%
3.63B
0.84%
4.70B
29.57%
3.32B
29.50%
9.58B
188.77%

All numbers in (except ratios and percentages)